Development and validation of a stability-indicating HPLC method for simultaneous determination of salicylic acid, betamethasone dipropionate and their related compounds in Diprosalic Lotion®

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 3, 2009, Pages 356-361

  Shou, Minshan ^a   Galinada, Wilmer A ^a   Wei, Yu Chien ^a   Tang, Qinglin ^a   Markovich, Robert J ^a   Rustum, Abu M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Betamethasone dipropionate; ChromSword; Diprosalic Lotion ; HPLC; Method development; Salicylic acid

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; 4 HYDROXYBENZOIC ACID; 4 HYDROXYISOPHTHALIC ACID; 6 BROMO, BETAMETHASONE DIPROPIONATE; 9 BROMO, BETAMETHASONE DIPROPIONATE; 9,11 ENE BETAMETHASONE DIPROPIONATE; ACETONITRILE; BECLOMETASONE DIPROPIONATE; BETAMETHASONE; BETAMETHASONE 11,17,21 TRIPROPIONATE; BETAMETHASONE 17 KETONE; BETAMETHASONE 17 PROPIONATE; BETAMETHASONE 17 PROPIONATE, 21 BUTYRATE; BETAMETHASONE 21 ACETATE, 17 PROPIONATE; BETAMETHASONE 21 PROPIONATE; BETAMETHASONE 9,11 EPOXIDE 17,21 DIPROPIONATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE ENOLALDEHYDE; CATECHOL; GENTISIC ACID; GLUCOCORTICOID; MESYLIC ACID; PHENOL; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IMPURITY; DRUG STABILITY; ELUTION; LOTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SHELF LIFE; ULTRAVIOLET SPECTROSCOPY; VALIDATION STUDY;

ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; DRUG STABILITY; SALICYLIC ACID;

EID: 67650272373     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.05.015     Document Type: Article

References (23)

1. Brazzine B., and Pimpinelli N. Am. J. Clin. Dermatol. 3 (2002) 47-58
2. Guenther L.C. Am. J. Clin. Dermatol. 5 (2004) 71-77
3. Elie R., Durocher L.P., and Kavalec E.C. J. Int. Med. Res. 11 (1983) 108-112
4. Li M., Chen B., Lin M.X., Chan T.M., Fu X.Y., and Rustum A.M. Tetrahedron Lett. 48 (2007) 3505-3901
5. Chen B., Li M., Lin M., Tumambac G., and Rustum A. Steriods 74 (2009) 30-41
6. Weiss G., Monder C., and Bradlow L. J. Clin. Endocrinol. Metab. 43 (1976) 696-699
7. Coudray C., Talla M., Martin S., Fatome M., and Favier A. Anal. Biochem. 227 (1995) 101-111
8. Grootveld M., and Halliwell B. Biochem. Pharmacol. 37 (1988) 271-280
9. Bruck S.D. Med. Prog. Technol. 16 (1990) 131-143
10. Jenke D. J. Pharm. Sci. Technol. 56 (2002) 332-371
11. Ibrahim H., Bouajila J., Couderc F., and Nepveu F. J. Chromatogr. B 857 (2007) 59-66
12. Kumar V.V.P., Vinu M.C.A., Ramani A.V., Mullangi R., and Srinivas N.R. Biomed. Chromatogr. 20 (2006) 125-132
13. Mikami E., Goto T., Ohno T., Matsumoto H., and Nishida M. J. Pharm. Biomed. Anal. 28 (2002) 261-267
14. Hassonville S.H., Chiap P., Liegeois J.F., Evrard B., Delattre L., Crommen J., Piel G., and Hubert P. J. Pharm. Biomed. Anal. 36 (2004) 133-143
15. Kedor-Hackmann E.R., Gianotto E.A., and Santoro M.I. Drug Dev. Ind. Pharm. 24 (1998) 553-555
16. Marini R.D., Pantella A., Bimazubete M.A., Chiap P., Hubert P.H., and Crommen J. Chromatographia 55 (2002) 263-269
17. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2, (R1).
18. Hovding G. Pharmatherapeutica 3 (1981) 61-66
19. Xiao K.P., Xiong Y., Liu F.Z., and Rustum A.M. J. Chromatogr. A 1163 (2007) 145-156
20. Papadopoulos N., and Avranas A. J. Sol. Chem. 20 (1991) 293-300
21. Zhu P.L., Snyder L.R., and Dolan J.W. J. Chromatogr. A 756 (1996) 41-50
22. Hancock W.S., Chloupek R.C., Kirkland J.J., and Snyder L.R. J. Chromatogr. A 686 (1994) 45-59
23. Zhu P.L., Snyder L.R., Dolan J.W., Hill D.W., Van Heukelem L., and Waeghe T.J. J. Chromatogr. A 756 (1996) 51-62